Mr Iomar Barrett, Celosia Therapeutics’ Series A investor and hedge fund manager, speaks about his investment philosophy as a biotech investor, and reasons why he… Read More »Video – Interview with Mr Iomar Barrett
In this video, Celosia Therapeutics co-founders Professor Lars Ittner and Professor Yazi Ke speak about the scientific discovery of CTx1000, Celosia’s lead asset, and its… Read More »Video – Interview with Prof Lars Ittner and Prof Yazi Ke
Celosia Therapeutics CEO and Director of Commercialisation at Macquarie University, Dr Kathryn Sunn sit down for an interview post the company’s landmark Series A funding… Read More »Video – Interview with Celosia Therapeutics CEO Dr Kathryn Sunn
Sydney, Australia, 28 November 2024 – Celosia Therapeutics, an Australian biotech company developing advanced gene therapies for neurodegenerative diseases, has completed one of the largest… Read More »Celosia Secures Landmark $16.75M Funding for Breakthrough ALS Gene Therapy